BioWorld MedTech

May 19, 2016

Short-term results blur promise of healing with Abbott's Absorb stent

PARIS – The question was projected onto a big screen almost as soon as the presentations began for results from registries on the Absorb Bioresorbable Vascular Scaffold (BVS) from Abbott Vascular, based in Abbott Park, Ill. Read More

Medtronic to buy Smith & Nephew's gynecology business for $350M

Mazor shines after inking spine solutions deal with Medtronic

Fosun makes play for India firm Gland Pharma

FDA approves Genentech's immunotherapy duo Tecentriq + diagnostic for bladder cancer

CMS cites availability in DME non-bidding areas as suspension bills in play

Appointments and advancements

Product briefs

Financings

MDD's Orthopedics Extra

Today's news in brief

BioWorld

BioWorld briefs for June 12, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for June 9, 2026

3D rendering of β2-Adrenergic receptor GPCR protein molecule embedded in lipid bilayer membrane.

Skape Bio unlocks GPCR targets with de novo-designed miniproteins

BioWorld

Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...

New 5-HT2C receptor agonists reported in Hansoh patent

BioWorld Science

Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...

Pre-disease plasma signature may help redefine lung cancer risk

BioWorld

Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...